Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Ironwood Pharmaceuticals revenue
Ironwood Pharmaceuticals's revenue is $351.4 million.
What is Ironwood Pharmaceuticals's revenue?
- Ironwood Pharmaceuticals's revenue growth from 2022 to 2024 is -14.41%.
- Ironwood Pharmaceuticals has 219 employees, and the revenue per employee ratio is $1,604,611.
- Ironwood Pharmaceuticals's peak quarterly revenue was $117.6M in 2023(q4).
- Ironwood Pharmaceuticals peak revenue was $442.7M in 2023.
- Ironwood Pharmaceuticals annual revenue for 2023 was 442.7M, 7.83% growth from 2022.
- Ironwood Pharmaceuticals annual revenue for 2024 was 351.4M, -20.63% growth from 2023.
On this page
Zippi applies for you, and finds you a job.
Ironwood Pharmaceuticals historical revenue
Ironwood Pharmaceuticals's peak revenue was $442.7M in 2023. The peak quarterly revenue was $117.6M in 2023(q4).
Ironwood Pharmaceuticals's revenue increased from $18.4m in 2022 to $351.4M currently. That's a -14.41% change in annual revenue.
Ironwood Pharmaceuticals annual revenue
Ironwood Pharmaceuticals annual revenue over time
| Fiscal year / year | Ironwood Pharmaceuticals revenue |
|---|---|
| 2022 | $410.6M |
| 2023 | $442.7M |
| 2024 | $351.4M |
Ironwood Pharmaceuticals quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Ironwood Pharmaceuticals quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2022 | $97.5M | $97.2M | $108.6M | $107.2M |
| 2023 | $104.1M | $107.4M | $113.7M | $117.6M |
| 2024 | $74.9M | $94.4M | $91.6M | $90.5M |
Ironwood Pharmaceuticals jobs nearby
Do you work at Ironwood Pharmaceuticals?
Did Ironwood Pharmaceuticals meet its revenue projections?
Ironwood Pharmaceuticals financial information
| CEO | Thomas McCourt |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 219 |
| Date Founded | 1998 |
| Headquarters | Cambridge, Massachusetts |
| Number of Locations | 2 |
| Revenue | $351.4M |
| Net Income | $175,065,000 |
| PE Ratio | 2405.23 |
| Tax Rate | 1.0% |
| Market Capitalization | $2.1B |
| Total Assets | $1,100,519,000 |
| Ticker | IRWD |
Ironwood Pharmaceuticals jobs you might like
Ironwood Pharmaceuticals financing
Ironwood Pharmaceuticals received early financing of $10.0M on 1999-01-01.
| Series | Round size | Date |
|---|---|---|
| Series A | $10M | 01/1999 |
| Series B | $23M | 11/2000 |
| Series C | $26M | 04/2002 |
| Series D | $50M | 05/2004 |
| Series E | $75M | 02/2006 |
| Series F | $50M | 03/2007 |
| Series G | $50M | 10/2008 |
| Series Unknown | $25M | 09/2009 |
| Post Ipo Debt | $175M | 01/2013 |
| Post Ipo Debt | $150M | 09/2016 |
Ironwood Pharmaceuticals investors
| Investors | Security type |
|---|---|
| Venrock | Series A |
| Venrock | Series B |
| Venrock | Series C |
| F Prime Capital | Series C |
| Venrock | Series D |
| GGV Capital | Series D |
| Venrock | Series E |
| Venrock | Series F |
| Morgan Stanley | Series F |
| Polaris Partners | Series Unknown |
Ironwood Pharmaceuticals competitors
Ironwood Pharmaceuticals's top competitor, Hoffmann-LA Roche Inc, earned an annual revenue of $60.9B.
Ironwood Pharmaceuticals's smallest competitor is eCardio with revenue of $12.0M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Vertex Pharmaceuticals | $95,952 | $11.0B | 3,400 | 140 |
| AstraZeneca | $112,988 | $25.9B | 76,100 | 33 |
| Cyberonics | $86,285 | $291.6M | 660 | - |
| Alnylam Pharmaceuticals | $81,014 | $2.2B | 1,323 | - |
| eCardio | $43,684 | $12.0M | 750 | - |
| Radius Health Inc | $54,903 | $230.0M | 730 | 27 |
| Ligand Pharmaceuticals | $82,001 | $241.5M | 116 | - |
| Hoffmann-LA Roche Inc | $93,461 | $60.9B | 101,200 | 173 |
Ironwood Pharmaceuticals revenue FAQs
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Ironwood Pharmaceuticals highest paying jobs
Zippia gives an in-depth look into the details of Ironwood Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Ironwood Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Ironwood Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Ironwood Pharmaceuticals. The data presented on this page does not represent the view of Ironwood Pharmaceuticals and its employees or that of Zippia.
Ironwood Pharmaceuticals may also be known as or be related to IRONWOOD PHARMACEUTICALS INC, Ironwood Pharmaceuticals, Ironwood Pharmaceuticals Inc and Ironwood Pharmaceuticals, Inc.